Biogen and Elan have reported two confirmed cases of a deadly brain infection - progressive multifocal leukoencephalopathy - in patients taking their Tysabri multiple sclerosis drug, according to a filing with the Securities and Exchange Commission.
Read article at pharmalot.com
Saturday, August 09, 2008
Biogen's Tysabri has caused brain infection in two patients
Posted by Willow at 5:50 pm
Labels: adverse side-effects, Biogen, multiple sclerosis, prescribed drugs, progressive multifocal leukoencephalopathy, Tysabri
Subscribe to: